These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9571052

  • 1. Ligand-induced domain movement in an antibody Fab: molecular dynamics studies confirm the unique domain movement observed experimentally for Fab NC6.8 upon complexation and reveal its segmental flexibility.
    Sotriffer CA, Liedl KR, Linthicum DS, Rode BM, Varga JM.
    J Mol Biol; 1998 May 01; 278(2):301-6. PubMed ID: 9571052
    [Abstract] [Full Text] [Related]

  • 2. Local and transmitted conformational changes on complexation of an anti-sweetener Fab.
    Guddat LW, Shan L, Anchin JM, Linthicum DS, Edmundson AB.
    J Mol Biol; 1994 Feb 11; 236(1):247-74. PubMed ID: 7893280
    [Abstract] [Full Text] [Related]

  • 3. Elbow flexibility and ligand-induced domain rearrangements in antibody Fab NC6.8: large effects of a small hapten.
    Sotriffer CA, Rode BM, Varga JM, Liedl KR.
    Biophys J; 2000 Aug 11; 79(2):614-28. PubMed ID: 10919996
    [Abstract] [Full Text] [Related]

  • 4. Circular dichroism spectroscopy of monoclonal antibodies that bind a superpotent guanidinium sweetener ligand.
    Tetin SY, Linthicum DS.
    Biochemistry; 1996 Jan 30; 35(4):1258-64. PubMed ID: 8573581
    [Abstract] [Full Text] [Related]

  • 5. Construction and characterization of two anti-sweetener single chain antibodies using radioligand binding, fluorescence and circular dichroism spectroscopy.
    Pledger DW, Brodnicki TC, Graham BL, Tetin S, Kranz DM, Linthicum DS.
    J Mol Recognit; 1999 Jan 30; 12(4):258-66. PubMed ID: 10440997
    [Abstract] [Full Text] [Related]

  • 6. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW, Shan L, Broomell C, Ramsland PA, Fan Z, Anchin JM, Linthicum DS, Edmundson AB.
    J Mol Biol; 2000 Sep 29; 302(4):853-72. PubMed ID: 10993728
    [Abstract] [Full Text] [Related]

  • 7. X-ray structure of the uncomplexed anti-tumor antibody BR96 and comparison with its antigen-bound form.
    Sheriff S, Chang CY, Jeffrey PD, Bajorath J.
    J Mol Biol; 1996 Jun 28; 259(5):938-46. PubMed ID: 8683596
    [Abstract] [Full Text] [Related]

  • 8. Cocrystal structures of NC6.8 Fab identify key interactions for high potency sweetener recognition: implications for the design of synthetic sweeteners.
    Gokulan K, Khare S, Ronning DR, Linthicum SD, Sacchettini JC, Rupp B.
    Biochemistry; 2005 Jul 26; 44(29):9889-98. PubMed ID: 16026161
    [Abstract] [Full Text] [Related]

  • 9. Analysis of correlated motion in antibody combining sites from molecular dynamics simulations.
    Viswanathan M, Linthicum DS, Subramaniam S.
    Methods; 2000 Mar 26; 20(3):362-71. PubMed ID: 10694457
    [Abstract] [Full Text] [Related]

  • 10. Three-dimensional structures of the Fab fragment of murine N1G9 antibody from the primary immune response and of its complex with (4-hydroxy-3-nitrophenyl)acetate.
    Mizutani R, Miura K, Nakayama T, Shimada I, Arata Y, Satow Y.
    J Mol Biol; 1995 Nov 24; 254(2):208-22. PubMed ID: 7490744
    [Abstract] [Full Text] [Related]

  • 11. Recognition of superpotent sweetener ligands by a library of monoclonal antibodies.
    Anchin JM, Nagarajan S, Carter J, Kellogg MS, DuBois GE, Linthicum DS.
    J Mol Recognit; 1997 Nov 24; 10(5):235-42. PubMed ID: 9587873
    [Abstract] [Full Text] [Related]

  • 12. Structural predictions of the binding site architecture for monoclonal antibody NC6.8 using computer-aided molecular modeling, ligand binding, and spectroscopy.
    Viswanathan M, Anchin JM, Droupadi PR, Mandal C, Linthicum DS, Subramaniam S.
    Biophys J; 1995 Sep 24; 69(3):741-53. PubMed ID: 8519975
    [Abstract] [Full Text] [Related]

  • 13. Identification of residues in monoclonal antibody NC10.8 that bind to the sweetener N-(p-cyanophenyl)-N'-(diphenylmethyl)guanidinoacetic acid by using radioligand binding, absorption and fluorescence spectroscopy, computer-aided molecular modeling, and site-directed mutagenesis.
    Anchin JM, Droupadi PR, DuBois GE, Kellogg MS, Nagarajan S, Carter JS, Linthicum DS.
    J Immunol; 1994 Oct 01; 153(7):3059-69. PubMed ID: 8089487
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the crystallographic structures of two catalytic antibodies with esterase activity.
    Buchbinder JL, Stephenson RC, Scanlan TS, Fletterick RJ.
    J Mol Biol; 1998 Oct 09; 282(5):1033-41. PubMed ID: 9753552
    [Abstract] [Full Text] [Related]

  • 15. Forces and energetics of hapten-antibody dissociation: a biased molecular dynamics simulation study.
    Paci E, Caflisch A, Plückthun A, Karplus M.
    J Mol Biol; 2001 Nov 30; 314(3):589-605. PubMed ID: 11846569
    [Abstract] [Full Text] [Related]

  • 16. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK, Woof JM, Kerr MA, Perkins SJ.
    J Mol Biol; 1999 Mar 12; 286(5):1421-47. PubMed ID: 10064707
    [Abstract] [Full Text] [Related]

  • 17. Anchoring a cationic ligand: the structure of the Fab fragment of the anti-morphine antibody 9B1 and its complex with morphine.
    Pozharski E, Wilson MA, Hewagama A, Shanafelt AB, Petsko G, Ringe D.
    J Mol Biol; 2004 Mar 26; 337(3):691-7. PubMed ID: 15019787
    [Abstract] [Full Text] [Related]

  • 18. Crystal structure of the liganded anti-gibberellin A(4) antibody 4-B8(8)/E9 Fab fragment.
    Murata T, Fushinobu S, Nakajima M, Asami O, Sassa T, Wakagi T, Yamaguchi I.
    Biochem Biophys Res Commun; 2002 Apr 26; 293(1):489-96. PubMed ID: 12054627
    [Abstract] [Full Text] [Related]

  • 19. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
    Talavera A, Friemann R, Gómez-Puerta S, Martinez-Fleites C, Garrido G, Rabasa A, López-Requena A, Pupo A, Johansen RF, Sánchez O, Krengel U, Moreno E.
    Cancer Res; 2009 Jul 15; 69(14):5851-9. PubMed ID: 19584289
    [Abstract] [Full Text] [Related]

  • 20. Structure of an anti-DNA fab complexed with a non-DNA ligand provides insights into cross-reactivity and molecular mimicry.
    Schuermann JP, Henzl MT, Deutscher SL, Tanner JJ.
    Proteins; 2004 Nov 01; 57(2):269-78. PubMed ID: 15340914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.